Dr. Lowell R Amiotte Ii, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 W Lakeway Suite 3, Northern Plains Anesthesia Associates, Gillette, WY 82718 Phone: 307-682-7819 |
Dr. William J. Forman, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-1524 Fax: 307-687-7243 |
Nita R. Engineer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-1824 Fax: 732-271-3543 |
Dr. Mark Lloyd Wisniewski, M.D. Anesthesiology - Pediatric Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1307 W 3rd St, #b, Gillette, WY 82716 Phone: 801-707-1874 |
Jessica Quinlan Ratledge, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-1000 |
Dr. Erik P. Johnsrud, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-1524 Fax: 307-687-7243 |
Dr. John L. Mansell, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 W Lakeway Rd, Suite 3, Gillette, WY 82718 Phone: 307-696-2996 Fax: 307-670-8250 |
Darlene K Brown, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 501 S Burma Ave, Gillette, WY 82716 Phone: 307-688-1824 Fax: 307-687-7243 |
News Archive
A survey of more than 3,400 university students in the USA has found that one in five respondents reported problematic smartphone use.
Pisgah Labs, a drug product development company and an active pharmaceutical ingredient manufacturer (API) located in western North Carolina, has received a patent allowance in a series of patent applications. The US Patent & Trademark Office (USPTO) has notified Pisgah Labs, Inc. that a patent application related to a therapeutically significant family of pharmaceutical polymorphic compositions of imipramine pamoate has been allowed. The patent application also includes methods of manufacturing, purifying and use in pharmaceutical preparations.
Among very low-birth-weight (VLBW) infants, the use of supplemental donor milk compared with formula did not improve neurodevelopment at 18 months, according to a study appearing in the November 8 issue of JAMA.
The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness.
› Verified 9 days ago